Publications by authors named "Sandra Borkowski"

Claim this Profile
D
Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.
Bert-Ram Sah, Irene A Burger, Roger Schibli, Matthias Friebe, Ludger Dinkelborg, Sandra Borkowski

J Nucl Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.
Ralf Lesche, Georg Kettschau, Alexey V Gromov, Niels Böhnke, Sandra Borkowski

Eur J Nucl Med Mol Imaging· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548.
Esa Kähkönen, Ivan Jambor, Jukka Kemppainen, Kaisa Lehtiö, Tove J Grönroos, Sandra Borkowski

Clin Cancer Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy men.
Anne Roivainen, Esa Kähkönen, Pauliina Luoto, Sandra Borkowski, Birte Hofmann

J Nucl Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin.
Rebecca A Dumont, MariaLuisa Tamma, Friederike Braun, Sandra Borkowski, Jean Claude Reubi

J Nucl Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.
Michael Honer, Linjing Mu, Timo Stellfeld, Keith Graham, Miljen Martic, Sandra Borkowski

J Nucl Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Beatrice Waser, Renzo Cescato, Sandra Borkowski

Eur J Nucl Med Mol Imaging· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.
Linjing Mu, Michael Honer, Jessica Becaud, Miljen Martic, Pius A Schubiger, Sandra Borkowski

Bioconjug Chem· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct one-step 18F-labeling of peptides via nucleophilic aromatic substitution.
Jessica Becaud, Linjing Mu, Mylène Karramkam, Pius A Schubiger, Simon M Ametamey, Sandra Borkowski

Bioconjug Chem· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Aileen Höhne, Linjing Mu, Michael Honer, P August Schubiger, Simon M Ametamey, Sandra Borkowski

Bioconjug Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.
Dietmar Berndorff, Sandra Borkowski, Dieter Moosmayer, Francesca Viti, Beate Müller-Tiemann

J Nucl Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
Dieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, Robert M Sharkey, Axel Rother, Sandra Borkowski

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor targeting by an aptamer.
Brian J Hicke, Andrew W Stephens, Ty Gould, Ying-Fon Chang, Cynthia K Lynott, Sandra Borkowski

J Nucl Med· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
Dietmar Berndorff, Sandra Borkowski, Stephanie Sieger, Axel Rother, Matthias Friebe

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
Kathrin S Schmidt, Sandra Borkowski, Jens Kurreck, Andrew W Stephens, Rolf Bald

Nucleic Acids Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis